Latest prostatectomy Stories
HoLEP attains rapid adoption and acceptance as the Proven Procedure for Treating BPH Yokneam, Israel (PRWEB) May 19, 2012 Lumenis Ltd., the world's largest
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate.
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships.
To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan.
Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States.